Cargando…
Toxicoproteomic Profiling of hPXR Transgenic Mice Treated with Rifampicin and Isoniazid
Tuberculosis is a global health threat that affects millions of people every year, and treatment-limiting toxicity remains a considerable source of treatment failure. Recent reports have characterized the nature of hPXR-mediated hepatotoxicity and the systemic toxicity of antitubercular drugs. The a...
Autores principales: | Brewer, Christopher Trent, Kodali, Kiran, Wu, Jing, Shaw, Timothy I., Peng, Junmin, Chen, Taosheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7407182/ https://www.ncbi.nlm.nih.gov/pubmed/32660103 http://dx.doi.org/10.3390/cells9071654 |
Ejemplares similares
-
Human PXR modulates hepatotoxicity associated with rifampicin and isoniazid co–therapy
por: Li, Feng, et al.
Publicado: (2013) -
Human pregnane X receptor is expressed in breast carcinomas, potential heterodimers formation between hPXR and RXR-alpha
por: Conde, Isabel, et al.
Publicado: (2008) -
PXR variants: the impact on drug metabolism and therapeutic responses
por: Brewer, C. Trent, et al.
Publicado: (2016) -
Mechanism Investigation of Rifampicin-Induced Liver Injury Using Comparative Toxicoproteomics in Mice
por: Kim, Ju-Hyun, et al.
Publicado: (2017) -
Up-Regulating CYP3A4 Expression in C3A Cells by Transfection with a Novel Chimeric Regulator of hPXR-p53-AD
por: Chen, Feng, et al.
Publicado: (2014)